← Leaderboards
Siddharth Balachandran
Research Inst Of Fox Chase Can Ctr
$16,302,354
Attributed
$23,708,715
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,708,715 · 14
By mechanism
R01$19,165,975 · 6
R56$2,330,446 · 3
R21$1,998,000 · 4
P30$214,294 · 1
Top collaborators
- Gregory D Cuny6 shared
- Alexei Degterev6 shared
- Joseph Robert Testa5 shared
- Vasily M Studitsky3 shared
- Cagla Tukel3 shared
- Ryan Langlois2 shared
- Carolina B. Lopez2 shared
Most similar at Research Inst Of Fox Chase Can Ctr
Same institution · by research overlap
- Vasily M Studitsky$6,950,102
- Craig Menges$989,268
- Joseph Testa$1,199,274
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsCessation Of LifeCell DeathMediatingVirus DiseasesSignal TransductionRipk3 GenePathway InteractionsIn VivoPreventMouse ModelCell TypePhosphotransferasesImmuneNecrosisInflammatoryProteinsProgramsInflammationInfectionMolecularSensorVirusInfluenza A Virus
Grant awards (50)
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death$1,460,069
R01 · FY2025 · AI · contact PI
Role of ZBP1 in pathogenesis of Salmonella biofilms$838,667
R01 · FY2025 · AI · contact PI
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy$758,985
R01 · FY2025 · CA · contact PI
Role of ZBP1 in pathogenesis of Salmonella biofilms$842,440
R01 · FY2024 · AI · contact PI
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy$721,035
R01 · FY2024 · CA · contact PI
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death$720,326
R01 · FY2024 · AI · contact PI
Role of ZBP1 in pathogenesis of Salmonella biofilms$846,101
R01 · FY2023 · AI · contact PI
Harnessing ZBP1-triggered cell death to enhance influenza vaccine responsiveness$833,534
R56 · FY2023 · AI · contact PI
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy$758,985
R01 · FY2023 · CA · contact PI
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death$720,326
R01 · FY2023 · AI · contact PI
Targeting RIPK3 in Flu-Associated Lung Injury$702,005
R01 · FY2023 · AI · contact PI
Necroptosis in SARS-CoV-2 pathogenesis, evolution, and therapy$233,000
R21 · FY2023 · AI · contact PI
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death$742,326
R01 · FY2022 · AI · contact PI
Targeting RIPK3 in Flu-Associated Lung Injury$731,691
R01 · FY2022 · AI · contact PI
Necroptosis in SARS-CoV-2 pathogenesis, evolution, and therapy$280,000
R21 · FY2022 · AI · contact PI
Harnessing ZBP1-driven cell death to improve influenza vaccine efficacy$847,917
R56 · FY2021 · AI · contact PI
Targeting RIPK3 in Flu-Associated Lung Injury$789,265
R01 · FY2021 · AI · contact PI
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death$577,887
R01 · FY2021 · AI · contact PI
Blood Cell Development and Function Program (02)$14,265
P30 · FY2021 · CA · contact PI
Targeting RIPK3 in Flu-Associated Lung Injury$678,878
R01 · FY2020 · AI · contact PI
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death$667,142
R01 · FY2020 · AI · contact PI
A New IFN-γ Activated Cell Death Pathway in Salmonella-infected Non-Phagocytic Cells$274,500
R21 · FY2020 · AI · contact PI
Blood Cell Development and Function Program (02)$39,433
P30 · FY2020 · CA · contact PI
Blood Cell Development and Function Program (02)$8,695
P30 · FY2020 · CA · contact PI
Targeting RIPK3 in Flu-Associated Lung Injury$719,078
R01 · FY2019 · AI · contact PI
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death$667,142
R01 · FY2019 · AI · contact PI
RIP1/3 Kinases as New Targets in Malignant Mesothelioma$410,657
R01 · FY2019 · CA
A New IFN-γ Activated Cell Death Pathway in Salmonella-infected Non-Phagocytic Cells$228,750
R21 · FY2019 · AI · contact PI
Blood Cell Development and Function Program (02)$36,892
P30 · FY2019 · CA · contact PI
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death$676,077
R01 · FY2018 · AI · contact PI
Targeting RIPK3 in Age-Related Inflammation and Injury$648,995
R56 · FY2018 · AG
RIP1/3 Kinases as New Targets in Malignant Mesothelioma$423,359
R01 · FY2018 · CA
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer$379,725
R01 · FY2018 · CA · contact PI
Blood Cell Development and Function Program (02)$33,197
P30 · FY2018 · CA · contact PI
Blood Cell Development and Function Program (02)$10,869
P30 · FY2018 · CA · contact PI
Blood Cell Development and Function Program (02)$5,967
P30 · FY2018 · CA · contact PI
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death$565,577
R01 · FY2017 · AI · contact PI
RIP1/3 Kinases as New Targets in Malignant Mesothelioma$435,685
R01 · FY2017 · CA
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer$379,725
R01 · FY2017 · CA · contact PI
Blood Cell Development and Function Program (02)$33,196
P30 · FY2017 · CA · contact PI
RIP1/3 Kinases as New Targets in Malignant Mesothelioma$426,992
R01 · FY2016 · CA
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer$370,388
R01 · FY2016 · CA · contact PI
Blood Cell Development and Function Program (02)$31,780
P30 · FY2016 · CA · contact PI
RIP1/3 Kinases as New Targets in Malignant Mesothelioma$414,666
R01 · FY2015 · CA
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer$370,388
R01 · FY2015 · CA · contact PI
Control of interferon-activated necrosis by a virus-triggered FADD checkpoint$267,750
R21 · FY2015 · AI · contact PI
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer$370,388
R01 · FY2014 · CA · contact PI
Picornavirus-initiated inflamation: novel parallels from Drosophila$267,750
R21 · FY2014 · AI · contact PI
Control of interferon-activated necrosis by a virus-triggered FADD checkpoint$223,125
R21 · FY2014 · AI · contact PI
Picornavirus-initiated inflamation: novel parallels from Drosophila$223,125
R21 · FY2013 · AI · contact PI